TargetMol

L-Kynurenine

Product Code:
 
TAR-T4928
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T4928-50mg50mg£104.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4928-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
L-Kynurenine is a key intermediate in the breakdown pathway of tryptophan. L-Kynurenine is a substrate of kynureninase, KMO, and KAT associated with the suppression of antitumor immune responses. It has been shown to inhibit allogeneic T-cell proliferation and to increase malignant U87 glioma cell invasion into a collagen matrix.
CAS:
2922-83-0
Formula:
C10H12N2O3
Molecular Weight:
208.217
Pathway:
Immunology/Inflammation; Metabolism
Purity:
0.9991
SMILES:
N[C@@H](CC(=O)c1ccccc1N)C(O)=O
Target:
AhR; Aryl Hydrocarbon Receptor; Endogenous Metabolite

References

Widner B , Sepp N , Kowald E , et al. Degradation of tryptophan in patients with systemic lupus erythematosus[J]. Oxygen Transport to Tissue XXXIII, 1999, 467:571-577. Moyer BJ, et al. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGF?, and IDO1. Toxicol Appl Pharmacol. 2016 Jun 1;300:13-24. Sakakibara K, et al. Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels. J Pharmacol Sci. 2015 Sep;129(1):31-7. Kolho K L , Pessia A , Jaakkola T , et al. Faecal and serum metabolomics in paediatric inflammatory bowel disease[J]. Journal of Crohns & Colitis, 2017, 11(3):321-334. Fukushima T , Iizuka H , Yokota A , et al. Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients[J]. PLOS ONE, 2014, 9. Enhanced Tryptophan Degradation in Systemic Lupus Erythematosus[J]. Immunobiology, 2000, 201(5):0-630. Hartai Z , Klivenyi P , Janaky T , et al. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease[J]. Journal of the Neurological Sciences, 2005, 239(1):31-35.